Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis
INTRODUCTION: OncotypeDX© Recurrence Score (RS) is a multigene panel used to aid therapeutic decision making in early-stage, estrogen receptor positive (ER+)/human epidermal growth factor receptor-2 negative (HER2-) breast cancer. AIM: To compare responses to neoadjuvant endocrine therapy (NET) in p...
में बचाया:
| मुख्य लेखकों: | , , , , , |
|---|---|
| स्वरूप: | मूलपाठ |
| भाषा: | अंग्रेज़ी |
| प्रकाशित: |
Elsevier
2021
|
| विषय: | |
| ऑनलाइन पहुंच: | https://pmc.ncbi.nlm.nih.gov/articles/PMC8142274/ https://pubmed.ncbi.nlm.nih.gov/34022714 http://dx.doi.org/10.1016/j.breast.2021.04.010 |
| टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|